199 related articles for article (PubMed ID: 28375481)
1. Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis.
De B; Rhome R; Doucette J; Buckstein M
Dis Esophagus; 2017 Apr; 30(4):1-10. PubMed ID: 28375481
[TBL] [Abstract][Full Text] [Related]
2. Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.
Brower JV; Chen S; Bassetti MF; Yu M; Harari PM; Ritter MA; Baschnagel AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):985-993. PubMed ID: 27869098
[TBL] [Abstract][Full Text] [Related]
3. Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy.
Kim JW; Kim TH; Kim JH; Lee IJ
World J Gastroenterol; 2018 Feb; 24(7):862-869. PubMed ID: 29467556
[TBL] [Abstract][Full Text] [Related]
4. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection.
Patel SA; Qureshi MM; Mak KS; Sahni D; Giacalone NJ; Ezzat W; Jalisi S; Truong MT
Head Neck; 2017 Jul; 39(7):1371-1377. PubMed ID: 28370725
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.
Buckstein M; Rhome R; Ru M; Moshier E
Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29309563
[TBL] [Abstract][Full Text] [Related]
6. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
[TBL] [Abstract][Full Text] [Related]
7. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.
Kim HJ; Suh YG; Lee YC; Lee SK; Shin SK; Cho BC; Lee CG
Cancer Res Treat; 2017 Jul; 49(3):669-677. PubMed ID: 27737537
[TBL] [Abstract][Full Text] [Related]
8. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
Zhang Z; Liao Z; Jin J; Ajani J; Chang JY; Jeter M; Guerrero T; Stevens CW; Swisher S; Ho L; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):656-64. PubMed ID: 15708243
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
10. National Practice Patterns for Clinical T1N0 Nasopharyngeal Cancer in the Elderly: A National Cancer Data Base Analysis.
Post CM; Lin C; Adeberg S; Gupta M; Zhen W; Verma V
Anticancer Res; 2018 Mar; 38(3):1651-1657. PubMed ID: 29491098
[TBL] [Abstract][Full Text] [Related]
11. Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer.
Ma SJ; Prezzano KM; Hermann GM; Singh AK
Radiat Oncol; 2018 Nov; 13(1):214. PubMed ID: 30400962
[TBL] [Abstract][Full Text] [Related]
12. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
13. Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database.
Brower JV; Amini A; Chen S; Hullett CR; Kimple RJ; Wojcieszynski AP; Bassetti M; Witek ME; Yu M; Harari PM; Baschnagel AM
Ann Oncol; 2016 Oct; 27(10):1887-94. PubMed ID: 27502703
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
[TBL] [Abstract][Full Text] [Related]
15. The effect of dose escalation for large squamous cell carcinomas of the anal canal.
Prasad RN; Elson J; Kharofa J
Clin Transl Oncol; 2018 Oct; 20(10):1314-1320. PubMed ID: 29623585
[TBL] [Abstract][Full Text] [Related]
16. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
[TBL] [Abstract][Full Text] [Related]
17. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma.
Haque W; Verma V; Butler EB; Teh BS
J Neurooncol; 2017 Jun; 133(2):369-375. PubMed ID: 28432588
[TBL] [Abstract][Full Text] [Related]
18. Patterns of care and survival outcomes in the treatment of esophageal melanoma.
Weiner JP; Shao M; Schwartz D; Wong A; Schreiber D
Dis Esophagus; 2017 Feb; 30(2):1-6. PubMed ID: 27862623
[TBL] [Abstract][Full Text] [Related]
19. Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer.
Natesan D; Hong JC; Foote J; Sosa JA; Havrilesky L; Chino J
Int J Gynecol Cancer; 2017 May; 27(4):794-804. PubMed ID: 28333840
[TBL] [Abstract][Full Text] [Related]
20. Academic Facility Utilization and Survival Outcomes in Adult Head and Neck Sarcomas: An NCDB Analysis.
Cannon RB; Carpenter PS; Boothe D; Buchmann LO; Hunt JP; Lloyd S; Hitchcock YJ; Houlton JJ; Weis JR; Shepherd HM; Monroe MM
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):473-483. PubMed ID: 29661049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
